Figure 4.
Figure 4. Analysis of CMPs, GMPs, and MEPs from e14.5 fetal liver. Representative e14.5, PU.1+/+ (n = 2), PU.1+/-(n = 5), or PU.1-/- (n = 3) fetal liver samples were stained with c-KitAPC, Sca-1TexasRed, Linbiotin/streptavidinPE-Cy5, FcγII/IIIPE, and CD34FITC and then analyzed by FACS. The percentage of CMPs, GMPs, and MEPs among total fetal liver cells is indicated. The percentages of Sca-1-cells are given as a percentage of the c-Kit+Lin- subset.

Analysis of CMPs, GMPs, and MEPs from e14.5 fetal liver. Representative e14.5, PU.1+/+ (n = 2), PU.1+/-(n = 5), or PU.1-/- (n = 3) fetal liver samples were stained with c-KitAPC, Sca-1TexasRed, Linbiotin/streptavidinPE-Cy5, FcγII/IIIPE, and CD34FITC and then analyzed by FACS. The percentage of CMPs, GMPs, and MEPs among total fetal liver cells is indicated. The percentages of Sca-1-cells are given as a percentage of the c-Kit+Lin- subset.

Close Modal

or Create an Account

Close Modal
Close Modal